At Heart Rhythm Society 2010, we saw intriguing new research into personalized afib treatment and stroke prevention that was presented by Dr. Nassir Marrouche and Dr. Marcos Daccarett of the Comprehensive Arrhythmia Research and Management (CARMA) Center at the University of Utah Health System. They have developed a way, using MRI (magnetic resonance imaging), to …
Read More
In preparation for the upcoming free community Atrial Fibrillation Seminar in Salt Lake City on Wednesday, May 19, renowned electrophysiologist Dr. Nassir Marrouche, the executive director of the University of Utah’s Comprehensive Arrhythmia Research & Management (CARMA) center, and Mellanie True Hills, founder of StopAfib.org, talked with NPR about heart disease and atrial fibrillation. Find …
Read More
Cardiothoracic surgeon Dr. James Edgerton of The Heart Hospital Baylor Plano (Plano, TX) spoke at an evening presentation at the Boston Atrial Fibrillation Symposium 2009 about the evolution and future of surgical procedures for atrial fibrillation. A full video transcript can be found at: stopafib.org
Read More
Cardiothoracic surgeon Dr. James Edgerton of The Heart Hospital Baylor Plano (Plano, TX) spoke at an evening presentation at the Boston Atrial Fibrillation Symposium 2009 about the evolution and future of surgical procedures for atrial fibrillation. A full video transcript can be found at: stopafib.org
Read More
Cardiothoracic surgeon, Dr. Ralph Damiano, of Barnes-Jewish Hospital in St. Louis, MO, spoke with StopAfib.org at Boston Atrial Fibrillation Symposium 2009. He shared information about new custom approaches to surgical and catheter ablation treatment of atrial fibrillation that he had presented at Boston Afib. A full video transcript can be …
Read More
In this video interview at Boston Atrial Fibrillation Symposium, Dr. Peter Kowey, President of the Main Line Health Heart Center, talked about a number of exciting new things in the atrial fibrillation world. His topics included the Cabana clinical trials, the Safari catheter ablation registry, dronedarone as a replacement for amiodarone, atrial selective drugs, and …
Read More
One of the most interesting things about atrial fibrillation is how geography—the location where you grew up, where you live now, and even where you visit—can affect your risk of atrial fibrillation and stroke. A fascinating map from the CDC (the Centers for Disease Control and Prevention) dramatically illustrates which parts of the country had …
Read More
Recently, Mellanie True Hills had the opportunity to visit with The Honorable William H. Frist, MD, Former US Senate Majority Leader, heart and lung transplant surgeon, and AF Stat Policy Advisor. Dr. Frist took a moment to record an overview of the importance of AF Stat for afib patients and …
Read More
In this video from Boston Atrial Fibrillation Symposium 2010, Dr. Andrea Natale discusses new directions in afib treatment, including hybrid procedures combining catheter ablation and surgery for chronic or persistent atrial fibrillation, and contact force sensing for determining the force applied during catheter ablation. Dr. Natale is the Executive Medical …
Read More
In this video from Boston Atrial Fibrillation Symposium 2010, Professor John Camm discusses the two newest antiarrhythmic drugs, dronedarone (Multaq®), which is now approved in the US and Europe for atrial fibrillation, and vernakalant, which is a year or two away. These antiarrhythmic (rhythm control) drugs help to put patients …
Read More